Brief: AnaptysBio's Complaint Against Tesaro For Breaching Agreement Was Publicly Filed On Nov 26 - SEC Filing
26/11/2025 21:09
Nov 26 (Reuters) - AnaptysBio Inc ANAB.O: ANAPTYSBIO INC - ON NOV 26, CO'S COMPLAINT AGAINST TESARO FOR BREACHING AGREEMENT WAS PUBLICLY FILED - SEC FILING ANAPTYSBIO INC - ON NOV 26, TESARO & GSK PUBLICLY FILED THEIR COMPLAINT AGAINST CO ALLEGING BREACHED COLLABORATION AGREEMENT Source text: [ID:n0001370053-25-000103] Further company coverage: ANAB.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on AnaptysBio
See all newsU.S. RESEARCH ROUNDUP- Applied Materials, NVIDIA, Thermo Fisher Scientific
AnaptysBio's Q1 collaboration revenue falls, net loss widens
Brief: AnaptysBio Q1 Net Income USD -52.884 Million
Brief: Anaptys Appoints Chris Murphy As Chief Financial Officer And Owen Hughes To Board Of Directors
Brief: GSK Says Unit Tesaro's Claim For Declaratory Judgment Against Anaptysbio Unchanged